An introduction to Exhalon, a spin-off from UVSQ / Foch Hospital / IHU SEPSIS, founded in 2025 by Stanislas Grassin-Delyle.
Image
Université Paris-Saclay has featured an article on this startup, which combines high-resolution mass spectrometry and artificial intelligence to deliver ultra-fast, non-invasive diagnosis of respiratory diseases directly from exhaled breath.
Article published on January 16, 2026.